Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Survival Prediction in HNSCC Based on Gene Expression Profiles From FFPE Tissues

NCT00897052 is registered in ClinicalTrials.gov with Vanderbilt-Ingram Cancer Center as lead sponsor.

NCT NCT00897052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00897052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Survival Prediction in HNSCC Based on Gene Expression Profiles From FFPE Tissues
Lead sponsor
Vanderbilt-Ingram Cancer Center
Phase
Observational
Overall status
Completed
Start date
February 28, 2005
Completion date
December 31, 2007
Enrollment
29 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer